Arrowstreet Capital’s China Life Insurance Company Ltd. LFC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,916,262
| Closed | -$42.5M | – | 1513 |
|
|
2022
Q2 | $42.5M | Sell |
4,916,262
-426,319
| -8% | -$3.25M | 0.06% | 244 |
|
|
2022
Q1 | $40.5M | Buy |
5,342,581
+110,853
| +2% | +$935K | 0.05% | 281 |
|
|
2021
Q4 | $43.1M | Sell |
5,231,728
-19,105
| -0.4% | -$164K | 0.05% | 313 |
|
|
2021
Q3 | $42.8M | Buy |
5,250,833
+2,545,769
| +94% | +$21.8M | 0.05% | 351 |
|
|
2021
Q2 | $26.9M | Buy |
2,705,064
+2,445,788
| +943% | +$25.1M | 0.03% | 500 |
|
|
2021
Q1 | $2.7M | Buy |
+259,276
| New | +$2.81M | ﹤0.01% | 1444 |
|
|
2020
Q3 | – | Sell |
-365,837
| Closed | -$3.69M | – | 2601 |
|
|
2020
Q2 | $3.69M | Buy |
365,837
+243,091
| +198% | +$2.45M | 0.01% | 1190 |
|
|
2020
Q1 | $1.2M | Buy |
122,746
+108,267
| +748% | +$1.3M | ﹤0.01% | 1254 |
|
|
2019
Q4 | $200K | Sell |
14,479
-316,566
| -96% | -$4.05M | ﹤0.01% | 1624 |
|
|
2019
Q3 | $3.81M | Sell |
331,045
-431,912
| -57% | -$5.27M | 0.01% | 786 |
|
|
2019
Q2 | $9.44M | Buy |
+762,957
| New | +$9.69M | 0.02% | 499 |
|
|
2019
Q1 | – | Sell |
-1,074,194
| Closed | -$11.3M | – | 1953 |
|
|
2018
Q4 | $11.3M | Sell |
1,074,194
-203,617
| -16% | -$2.17M | 0.03% | 408 |
|
|
2018
Q3 | $14.6M | Buy |
+1,277,811
| New | +$15.2M | 0.03% | 347 |
|
|
2018
Q2 | – | Sell |
-878,134
| Closed | -$12.3M | – | 1364 |
|
|
2018
Q1 | $12.3M | Sell |
878,134
-503,585
| -36% | -$7.73M | 0.03% | 401 |
|
|
2017
Q4 | $21.6M | Buy |
1,381,719
+288,279
| +26% | +$4.69M | 0.05% | 292 |
|
|
2017
Q3 | $16.5M | Buy |
1,093,440
+970,633
| +790% | +$15.2M | 0.04% | 302 |
|
|
2017
Q2 | $1.88M | Buy |
+122,807
| New | +$1.9M | 0.01% | 670 |
|
|
2016
Q4 | – | Sell |
-56,500
| Closed | -$739K | – | 2672 |
|
|
2016
Q3 | $739K | Sell |
56,500
-176,000
| -76% | -$2.12M | ﹤0.01% | 1147 |
|
|
2016
Q2 | $2.5M | Buy |
232,500
+155,409
| +202% | +$1.74M | 0.01% | 766 |
|
|
2016
Q1 | $947K | Sell |
77,091
-1,345,249
| -95% | -$16.2M | ﹤0.01% | 987 |
|
|
2015
Q4 | $22.7M | Sell |
1,422,340
-1,902,634
| -57% | -$33.9M | 0.1% | 191 |
|
|
2015
Q3 | $57.8M | Sell |
3,324,974
-796,990
| -19% | -$14.5M | 0.27% | 82 |
|
|
2015
Q2 | $89.7M | Sell |
4,121,964
-301,578
| -7% | -$7.18M | 0.51% | 53 |
|
|
2015
Q1 | $97.4M | Buy |
4,423,542
+1,286,967
| +41% | +$26.3M | 0.6% | 37 |
|
|
2014
Q4 | $61.4M | Buy |
3,136,575
+591,492
| +23% | +$9.31M | 0.35% | 68 |
|
|
2014
Q3 | $35.4M | Buy |
2,545,083
+238,737
| +10% | +$3.43M | 0.19% | 132 |
|
|
2014
Q2 | $30.1M | Sell |
2,306,346
-10,269
| -0.4% | -$139K | 0.16% | 141 |
|
|
2014
Q1 | $32.7M | Sell |
2,316,615
-710,460
| -23% | -$9.96M | 0.2% | 123 |
|
|
2013
Q4 | $47.7M | Buy |
3,027,075
+435,486
| +17% | +$6.3M | 0.26% | 98 |
|
|
2013
Q3 | $33.6M | Buy |
2,591,589
+707,955
| +38% | +$8.86M | 0.21% | 120 |
|
|
2013
Q2 | $21.9M | Buy |
+1,883,634
| New | +$24.6M | 0.16% | 135 |
|
Other funds holding LFC
HJIM
CCP
TRCT
BTI
IA
ACA
SSG
SPIA
Arrowstreet Capital's LFC Position: Q3 2022 in Review
Arrowstreet Capital sold out of China Life Insurance Company Ltd. (LFC) in Q3 2022, closing a stake of 4,916,262 shares — an estimated $42.5M sold.
Arrowstreet Capital first reported a position in LFC in Q2 2013 and held it in 31 quarters. The position peaked at $97.4M in Q1 2015. 13 funds tracked by Wall St. Rank hold LFC as of Q3 2022.
- Arrowstreet Capital reported no remaining China Life Insurance Company Ltd. position as of Q3 2022 after selling out during the quarter.
- Arrowstreet Capital sold 4,916,262 China Life Insurance Company Ltd. shares in Q3 2022, an estimated $42.5M.
- Arrowstreet Capital first reported a position in China Life Insurance Company Ltd. in Q2 2013 and held it in 31 quarters.
- Arrowstreet Capital's China Life Insurance Company Ltd. position peaked at $97.4M in Q1 2015.
- 13 funds tracked by Wall St. Rank held China Life Insurance Company Ltd. as of Q3 2022.
Based on Arrowstreet Capital's 13F filing for Q3 2022, filed 14 Nov 2022.